iifl-logo

Ajanta Pharma Ltd Dividend

2,523.2
(-1.01%)
Nov 14, 2025|12:00:00 AM

Ajanta Pharma CORPORATE ACTIONS

15/11/2024calendar-icon
15/11/2025calendar-icon
PurposeAnnouncement DateEx-DateRecord DateDividend AmountDividend per ShareRemark
Dividend3 Nov 202510 Nov 202510 Nov 2025281400Interim 1
1st interim dividend for the year FY 2026. Each share of Rs. 2 face value will receive a dividend of Rs. 28, amounting to Rs. 349.82 cr

Ajanta Pharma: Related News

Ajanta Pharma Q4 Profit Rises 11% to ₹225 Crore

Ajanta Pharma reported a strong EBITDA margin of 25% in the quarter.

30 Apr 2025|04:50 PM
Read More
Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.